Eleven rounds into 2026, the numbers say the sport’s strategic instincts are out of date. The undercut is succeeding at 86 percent, far above ...

Amplia Therapeutics has pointed to new preclinical data showing its pancreatic cancer drug candidate narmafotinib can hit several drivers of the intractable disease.

Craig Fuller has purchased financially struggling media outlets before, but took a leap on Thursday with the purchase of the ...

This year, Apple customers are racing to snap up iPhones after a global crunch in memory chip supplies prompted Apple to ...

Q2 introduced a major noncash item not present in Q1 results: a $47.2 million goodwill impairment charge tied to DWS, which CFO McCann said “reflects a slower pace of profitability improvement due to ...

The other two are Samsung and SK Hynix, a pair of South Korean outfits that dominate the market for the more mundane memory chips in phones, laptops and, increasingly, data centres. Their windfall ...

Meta gave a disappointing quarterly revenue forecast, stepping up pressure on Mark Zuckerberg to allay investor concerns that ...

Shareholders are growing increasingly antsy over its ability to bring in sales and profit at a fast enough pace ...

Jensen Huang just called AI infrastructure the largest expansion in human history, yet NVIDIA shares sit $20 below a $5 ...

Relation unveiled MORGAN, an AI “foundation model of the cell,” plus a GSK deal worth up to $110m to make the data to train it.

Analysts on Wall Street are gaining confidence in Microsoft's artificial intelligence strategy after the tech giant released its latest quarterly figures. The "Magnificent Seven" name reported fiscal ...

For this edition of Smart Mode, we look at the world of free web apps designed to help you accomplish a small, specific task.